Severe adenovirus infection outbreak in Colombia: Experience from a tertiary pediatric hospital in 2022

Natalia Vélez-Tirado1, Lina Castaño-Jaramillo1, Sonia Restrepo-Gualteros2

  • 1Departamento de Inmunología Pediátrica, Fundación Hospital Pediátrico La Misericordia, Bogotá, D.C., Colombia.

Insights

Severe adenovirus infections surged in Colombian children under five in 2022, causing a concerning outbreak. This study highlights increased pediatric intensive care unit admissions and mortality rates following eased public health restrictions.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Epidemiology

Background:

  • The SARS-CoV-2 pandemic altered respiratory virus circulation patterns globally.
  • Post-pandemic periods saw unusual outbreaks of common viruses.
  • Concerns arose regarding immune debt in young children due to reduced pathogen exposure.

Purpose of the Study:

  • To characterize severe adenovirus infections in pediatric patients in Colombia.
  • To investigate the clinical presentation and outcomes of adenovirus cases.
  • To assess the impact of eased public health measures on pediatric adenovirus outbreaks.

Main Methods:

  • Retrospective review of 227 patients with severe adenovirus infection.
  • Data collected from Fundación Hospital Pediátrico La Misericordia.
  • Analysis of clinical characteristics and outcomes for 196 patients.

Main Results:

  • Adenovirus was confirmed in all analyzed patient samples.
  • The median age of affected children was two years, with 62% males.
  • 97% required pediatric intensive care unit admission, 94% needed respiratory support, and 11% in-hospital mortality.

Conclusions:

  • 2022 witnessed a significant outbreak of severe adenovirus infections in young children (<5 years).
  • This outbreak exhibited higher-than-usual mortality rates.
  • Findings suggest a link between eased public health restrictions and increased adenovirus severity in pediatric populations.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
218
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
624
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
205